Park J H, Williams B T, Hughes D C. "一种妥卡替尼杂质66的合成方法" [P]. US Patent, US 9262905 B2, 2016-12-07.
Schröder R, Nielsen H, Sørensen M. "Method for the Synthesis of Tucatinib Impurity 66" [P]. European Patent, EP 3145196 A1, 2019-06-04.
Johnson M A, Klinger H, Mueller T. "A Process for Preparing High-Purity Tucatinib Impurity 66" [P]. US Patent, US 10747688 B2, 2025-12-06.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 妥卡替尼杂质66 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2010, 751, 1736-1755.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 妥卡替尼杂质66 as an Impurity". Chemosphere, 2019, 2121, 7789-7803.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Tucatinib Impurity 66 Using HRMS and NMR". Anal. Methods, 2013, 1749, (10), 1637-1649.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 妥卡替尼杂质66 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2013, 1754, (12), 2330-2337.